# Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment

> **NCT06367387** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Erin Winstanley** · enrollment: 268 (estimated)

## Conditions studied

- Opioid Use Disorder
- Chronic Pain

## Interventions

- **DRUG:** Patient-Oriented Dosing (POD)
- **BEHAVIORAL:** Pain Self-Management (PSM)
- **BEHAVIORAL:** Usual Care
- **DRUG:** Standard Buprenorphine Dosing Condition

## Key facts

- **NCT ID:** NCT06367387
- **Lead sponsor:** Erin Winstanley
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-28
- **Primary completion:** 2026-02-09
- **Final completion:** 2026-10-31
- **Target enrollment:** 268 (ESTIMATED)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06367387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06367387, "Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06367387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*